Business Description
Instil Bio Inc. is a clinical-stage biopharmaceutical company founded in 2018 and based in Dallas, Texas, that develops new treatments for cancer. Its lead drug candidate, AXN-2510/IMM2510, is currently being tested in clinical trials both in the United States and China across a range of difficult-to-treat cancers, including lung cancer, breast cancer, liver cancer, and several rare tumor types.
